SNOA Sonoma Pharmaceuticals, Inc.

$1.18 +0.85%

Healthcare · Surgical & Medical Instruments & Apparatus

Sonoma Pharmaceuticals, Inc. (SNOA) is a healthcare company in the Surgical & Medical Instruments & Apparatus industry, with a market capitalization of $6 million. Shares last traded at $1.18, 85.6% below their 52-week high. Over the past year the stock is down 63.2%. Net profit margin is -16.3%, below the peer median of -7.6%. Revenue grew 36.7% year over year.

Market Cap

$6M

Shares Out

4.8M

EPS (TTM)

$-5.80

P/E Ratio

—

P/S Ratio

0.29

P/B Ratio

1.82

Dividend / Share

—

Dividend Yield

—

52-Week High

$8.22

52-Week Low

$0.88

Volume

1,787

Avg Vol (3m)

4,509.095

Performance

+6.31%

+15.69%

-52.80%

-63.69%

YTD

-67.27%

-63.18%

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)

47.50

SMA (50)

$1.40

SMA (200)

$3.07

Price vs SMA50

-15.70%

Price vs SMA200

-61.58%

ATR (14)

$0.08

Financials

Revenue

$20M

Net Income

$-3M

Gross Margin

38.0%

Operating Margin

-12.6%

Net Margin

-16.3%

Return on Equity

-102.6%

Return on Assets

-22.7%

Current Ratio

2.50

Debt / Equity

0.00

Revenue Growth (YoY)

+36.7%

Latest reported annual period ending 2026-03-31 · SEC EDGAR/XBRL.

Recent earnings

Period	EPS (diluted)	Reported
FY 2026	$-1.89	2026-06-16
Q3 2026	$-1.56	2026-02-10
Q2 2026	$-1.08	2025-11-04
Q1 2026	$-0.76	2025-08-07
FY 2026	$-2.79	2026-06-16
Q3 2026	$-2.40	2026-02-10

Full earnings history →

Surgical & Medical Instruments & Apparatus peers

SNOA vs 14 industry peers (Surgical & Medical Instruments & Apparatus), by market cap.

P/S vs peers

0.29 / 2.52 med

-89% discount

Net margin vs peers

-16.3% / -7.6% med

below median

1–14 of 14


SYK	Stryker Corporation	$118.1B	36.38	4.70	12.9%	+2.28%
MMM	3M	$83.9B	25.82	3.36	13.0%	+1.10%
BSX	Boston Scientific	$67.3B	23.27	3.35	14.4%	+0.64%
BDX	Becton Dickinson	$39.7B	23.64	1.82	7.7%	+1.62%
MDLN	Medline Inc.	$29.4B	—	—	—	-1.47%
DXCM	DexCom	$28.0B	33.43	6.00	17.9%	+1.69%
RMD	ResMed	$27.4B	19.53	5.32	27.2%	+1.24%
WST	West Pharmaceutical Services	$23.2B	46.92	7.54	16.1%	+1.35%
SOLV	Solventum	$13.1B	—	—	—	+1.21%
PEN	Penumbra Inc	$12.5B	70.18	8.88	12.7%	+0.28%
GMED	Globus Medical Inc	$10.8B	19.99	3.66	18.3%	+5.00%
BAX	Baxter International	$10.3B	-10.74	0.91	-8.5%	+2.58%
PODD	Insulet Corporation	$10.1B	40.84	3.73	9.1%	+1.51%
GKOS	Glaukos Corp	$7.7B	-40.92	15.13	-37.0%	+2.53%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.